Research.Patient.info
Polycystic ovary syndrome (PCOS) research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS).
This study is looking at a new combination of medicines (SPIOMET) to see if it helps teenage girls and young women with Polycystic Ovary Syndrome (PCOS) ovulate more regularly. It will also check how safe and well-tolerated the treatment is.
Austria · Spain · Denmark - not yet recruitingNA
App Impact on Quality of Life and Symptoms in PCOS
This study looks at how a special app might help people with Polycystic Ovary Syndrome (PCOS) feel better and manage their symptoms. We want to see if using the app for 12 weeks improves quality of life and reduces PCOS symptoms compared to not using it.
Germany